These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10905240)

  • 21. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia.
    Hsu PI; Lai KH; Tseng HH; Lo GH; Lo CC; Lin CK; Cheng JS; Chan HH; Ku MK; Peng NJ; Chien EJ; Chen W; Hsu PN
    Aliment Pharmacol Ther; 2001 Feb; 15(2):195-201. PubMed ID: 11148437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
    Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
    Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
    Gisbert JP; Hermida C; Pajares JM
    Hepatogastroenterology; 2001; 48(41):1383-8. PubMed ID: 11677970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.
    Koelz HR; Arnold R; Stolte M; Fischer M; Blum AL;
    Gut; 2003 Jan; 52(1):40-6. PubMed ID: 12477757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
    Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study.
    Miwa H; Hirai S; Nagahara A; Murai T; Nishira T; Kikuchi S; Takei Y; Watanabe S; Sato N
    Aliment Pharmacol Ther; 2000 Mar; 14(3):317-24. PubMed ID: 10735925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori eradication in functional dyspepsia: HEROES trial.
    Mazzoleni LE; Sander GB; Francesconi CF; Mazzoleni F; Uchoa DM; De Bona LR; Milbradt TC; Von Reisswitz PS; Berwanger O; Bressel M; Edelweiss MI; Marini SS; Molina CG; Folador L; Lunkes RP; Heck R; Birkhan OA; Spindler BM; Katz N; Colombo Bda S; Guerrieri PP; Renck LB; Grando E; Hocevar de Moura B; Dahmer FD; Rauber J; Prolla JC
    Arch Intern Med; 2011 Nov; 171(21):1929-36. PubMed ID: 22123802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
    Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR
    Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
    Hsu CC; Lu SN; Changchien CS
    Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A placebo-controlled randomized trial of eradication of Helicobacter pylori in the general population: study design and response rates of the Bristol Helicobacter Project.
    Lane JA; Harvey RF; Murray LJ; Harvey IM; Donovan JL; Nair P; Egger M
    Control Clin Trials; 2002 Jun; 23(3):321-32. PubMed ID: 12057883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 35. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
    Veldhuyzen van Zanten S; Fedorak RN; Lambert J; Cohen L; Vanjaka A
    Am J Gastroenterol; 2003 Sep; 98(9):1963-9. PubMed ID: 14499772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
    Schwizer W; Thumshirn M; Dent J; Guldenschuh I; Menne D; Cathomas G; Fried M
    Lancet; 2001 Jun; 357(9270):1738-42. PubMed ID: 11403809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
    McColl KE; el-Nujumi A; Murray LS; el-Omar EM; Dickson A; Kelman AW; Hilditch TE
    Gut; 1998 May; 42(5):618-22. PubMed ID: 9659153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
    McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T
    N Engl J Med; 1998 Dec; 339(26):1869-74. PubMed ID: 9862941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
    García-Romero E; del Val A; Garrigues V; Cuquerella J; Higón MD; Barrachina M; Pons V; Bixquert M; Ponce J
    Gastroenterol Hepatol; 1999 Jan; 22(1):1-6. PubMed ID: 10089703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.